Bristol Myers Squibb and ConcertAI Announce Launch of Digital Clinical Trial Solution

Published on: 

ConcertAI announced the launch of its new Digital Trial Software-as-a-Service solution. Developed in partnership with Bristol Myers Squibb and powered by ConcertAI's real-world data, Digital Trial Solution integrates clinical research and clinical practice to simplify patient identification, consent, IRB approval, and contract negotiations.

Read more about the solution here.